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The effects of Mn2+ cation concentration on the ac magnetically induced heating characteristics and
the magnetic properties of superparamagnetic MnxZn1−xFe2O4 nanoparticles SPNPs were
investigated to explore the biotechnical feasibility as a hyperthermia agent. Among the
MnxZn1−xFe2O4 SPNPs, the Mn0.5Zn0.5Fe2O4 SPNP showed the highest ac magnetically induced
heating temperature Tac,mag, the highest specific absorption rate SAR, and the highest
biocompatibility. The higher out of phase susceptibility m  value and the higher chemical stability
systematically controlled by the replacement of Zn2+ cations by the Mn2+ cations on the A-site
tetrahedral site are the primary physical reason for the promising biotechnical properties of
Mn0.5Zn0.5Fe2O4 SPNP. © 2010 American Institute of Physics. doi:10.1063/1.3430043
Magnetic hyperthermia MH using a superparamagntice
nanoparticle agent SPNA has recently drawn huge attrac-
tion due to its clinical promises.1,2 Accordingly, the interests
to utilize the ternary phase of SPNPs, MFe2O4 M=Fe, Co,
Ni, and Mg, with a mean diameter below 10 nm for a MH
agent has increased dramatically. However, despite their
promising chemical, physiological, biotechnical, and physi-
cal properties suitable for SPNA applications,3 an insufficient
Tac,mag and low specific absorption rate SAR at the physi-
ologically tolerable range of frequencies and magnetic fields
fappl100 kHz, Happl200 Oe are still revealed as the
technical challenges to be overcome for a real clinical MH.4,5
Thus, a great deal of research activity is being conducted in
order to develop a functional SPNA and to improve the effi-
ciency of currently used ferrite SPNAs. The quarterly phase
of bulk MnxZn1−xFe2O4, which is one of the softest or
the highest permeability ferrite materials, is considered
to be a potential material for MH agent. The main physical
reason is that it has a good electrical field absorption
and a large power loss 500–200 W /m3 at a low frequency
100 kHz which is due to its low electrical resistivity
0.02–20  m.6,7 Furthermore, its magnetic properties, i.e.,
saturation magnetization, Ms, and magnetic susceptibility
m=m + im , particularly m , which are directly relevant
to the Tac,mag characteristics, can be easily controlled by
adjusting the relative concentration of Mn2+ and Zn2+ cations
in the MnxZn1−xFe2O4.
6,8,9 However, all of the works rel-
evant to the MnxZn1−xFe2O4 done so far were entirely fo-
cused on magnetoelectronics device applications.10 There
have been no systematic studies on the magnetic properties,
Tac,mag characteristics, and the biocompatibility of
MnxZn1−xFe2O4 SPNPs for MH agent applications until now.
In this paper, we report on the effects of Mn2+ cation
concentration on the magnetic properties and the Tac,mag
characteristics of MnxZn1−xFe2O4 SPNPs to explore its fea-
sibility as a MH agent. The physical correlation between the
magnetic properties of MnxZn1−xFe2O4 SPNPs controlled by
the Mn2+ cation concentration and Tac,mag, characteristics
including power loss mechanism were systematically inves-
tigated at different ac Happl and fappl. In addition, the cell
viability of MnxZn1−xFe2O4 SPNPs with different Mn
2+ cat-
ion concentrations were quantitatively analyzed to evaluate
the biocompatibility for in vivo MH agent applications.
The spinel ferrite MnxZn1−xFe2O4 nanoparticles NPs
with different Mn2+ cation concentration were synthesized
using a modified high temperature thermal decomposition
HTTD method, where ramping up rate and heat treatment
time were changed to 8.5 °C /min and 25 min, respectively,
compared to a conventional HTTD method.11 The Mn2+ cat-
ion concentration of MnxZn1−xFe2O4 NPs was systematically
controlled from x=0.2 to 0.8 during the synthesis. The crys-
tal structure, the particle size, and the distribution of
MnxZn1−xFe2O4 NPs were analyzed by using a Cu-k radi-
ated x-ray diffractometer XRD and a high resolution trans-
mission electron microscopy HRTEM. The Tac,mag char-
acteristics and the ac magnetic hysteresis of the solid state
MnxZn1−xFe2O4 NPs were measured by using an ac solenoid
coil system, which is connected to a capacitor. The fappl and
the Happl were varied from 30 kHz to 210 kHz and from 60
Oe to 140 Oe, respectively. The dc magnetic properties of the
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solid state MnxZn1−xFe2O4 NPs were analyzed by using a
vibrating sample magnetometer and the ac m was measured
by using an ac magnetosusceptometer. The zero field
cooling/field cooling ZFC/FC measurement was carried out
to characterize the dependence of temperature on the mag-
netic properties of MnxZn1−xFe2O4 NPs using a supercon-
ducting quantum interference device SQUID. The cell vi-
ability was quantitatively analyzed by employing
the methylthiazol tetrazolium bromide test MTT using
neuronal stem cells NSCs isolated from human fetal mid-
brain. The MnxZn1−xFe2O4 NPs were dispersed into the
mixed media of 2.5% alcohol, Dulbeco’s modified eagle’s
medium, 10% fetal bovine serum, 1% penicillin streptomy-
cin, and 2 mM glutamine. The concentration of
MnxZn1−xFe2O4 NPs in the media were varied
from 5 to 25 g /ml.
Prior to studying the magnetic properties and the
Tac,mag characteristics, the crystal structure, the particle size
and the distribution of MnxZn1−xFe2O4 NPs were first inves-
tigated. As can be seen in Fig. 1, all of the MnxZn1−xFe2O4
NPs had a mean particle size of 5.7–6 nm with a 12% stan-
dard deviation and they were well segregated with a round
shapes. In addition, the MnxZn1−xFe2O4 NPs showed a single
phase cubic spinel ferrite structure and did not exhibit any
undesirable crystalline phases. The well controlled structural
and chemical stabilities of MnxZn1−xFe2O4 NPs demonstrate
that they can be considered to be an in vivo MH agent be-
cause they are expected to minimize the biochemical reac-
tion with chemical components in the blood stream and to
allow for stable intravenous circulation.
Figure 2 shows the hysteresis loops of MnxZn1−xFe2O4
NPs measured under an externally applied field of a
=10 kOe and b =80 Oe at room temperature. All of
the MnxZn1−xFe2O4 NPs had superparamagnetic SP prop-
erties. Furthermore, the ZFC/FC measurement results not
shown in this paper confirmed that the blocking temperature
of MnxZn1−xFe2O4 NPs is in the range of 80–120 K depend-
ing on the Mn2+ cation concentration, indicating that they
have a SP phase at room temperature. As shown in Fig. 2a,
the Ms had a strong dependence on the Mn
2+ cation concen-
tration. Particularly, the Mn0.5Zn0.5Fe2O4 NPs had the high-
est Ms value of a 47 emu/g. The increase in Ms by increasing
the Mn2+ cation concentration up to x=0.5 is thought to be
due to the increase in magnetic moment of the unit cell up to
7.5 B B: Bohr magneton which resulted from the re-
placement of Zn2+ ions by Mn2+ ions on the A-site. However,
increasing the Mn2+ cation concentration above x=0.5 was
found to decrease the Ms. This decrease in Ms is due to the
development of antiferromagnetic alignment of Fe3+ ions on
the B-site see Fig. 3c.6
Figure 3 shows the dependence of Mn2+ cation concen-
tration on the Tac,mag and the magnetic properties of
MnxZn1−xFe2O4 SPNPs. In Fig. 3a, it can be clearly ob-
served that the Tac,mag measured at a constant Happl
=80 Oe, fappl=210 kHz had a strong dependence
on the Mn2+ cation concentration. The Tac,mag of
MnxZn1−xFe2O4 SPNPs was increased by increasing the Mn
concentration and reached a maximum Tac,mag=39 °C at
the composition of Mn0.5Zn0.5Fe2O4. A further increase in
Mn concentration, x	0.5, led to a severe reduction in
Tac,mag. The physical dependence of fappl and Happl on the
Tac,mag is shown in Fig. 3b. It was clearly demonstrated
that the Tac,mag is linearly proportional to the fappl and
squarely proportional to the Happl. These results strongly im-
ply that the physical nature of Tac,mag of MnxZn1−xFe2O4
FIG. 1. HRTEM images and XRD patterns of synthesized superparamag-
netic MnxZn1−xFe2O4 nanoparticles with different Mn composition: a x
=0.33, b x=0.5, c x=0.67, and d XRD patterns.
FIG. 2. Magnetic hysteresis loops of MnxZn1−xFe2O4 nanoparticles with
different Mn2+ cation concentration changed from x=0.2 to 0.8. a Major
loop and b minor loop.
FIG. 3. Dependence of Mn2+ cation concentration on the a ac magnetically
induced heating characteristics measured at the fixed Happl=80 Oe and
fappl=210 kHz, b applied frequency and magnetic field, and c SAR,
heating power total and relaxation loss, magnetization, out of phase sus-
ceptibility and ac magnetic coercivity of superparamagnetic MnxZn1−xFe2O4
nanoparticles  SAR,  magnetization dc,  Ptotal,  Prelaxation loss,  ac
susceptibility, and  coercivity ac.
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SPNPs is dominantly related to the “relaxation loss” heating
power, Prelaxation loss, as described in Eqs. 1 and 2.
12 Fur-
thermore, from this point of view, the highest Tac,mag value
obtained from the Mn0.5Zn0.5Fe2O4 SPNP can be understood
to be due to its highest measured m value which resulted
from its softest magnetic property as well as its largest ex-
change energy induced by the half portion of Zn2+ ions re-
placed by the Mn2+ ions on the A-site.
























 · 0 expKuV/kBT
,soft ferrite:N  B , 2
where N: Néel relaxation time, B: Brownian relaxation
time, 0:relaxation factor, and Ku: magnetic anisotropy.
The ac magnetic coercivity of MnxZn1−xFe2O4 SPNPs
measured at Happl= 80 Oe and fappl=210 kHz is shown in
Fig. 3c. The Mn0.5Zn0.5Fe2O4 SPNP exhibited the smallest
ac magnetic coercivity among the MnxZn1−xFe2O4 SPNPs
indicating that it has the lowest ac magnetic anisotropy re-
sulting in the fastest N or the highest m described in Eq.
2. This experimental result provides strong physical evi-
dence that the highest Tac,mag of Mn0.5Zn0.5Fe2O4 SPNP
x=0.5 is related directly to the well-controlled highest m .
Furthermore, this indicates that controlling the ac magnetic
softness of SPNPs, which is directly relevant to the Néel
relaxation behavior, is the most crucial factor in determining
the Tac,mag characteristics. In order to further clarify the
physical mechanism of Tac,mag of MnxZn1−xFe2O4 SPNPs,
the contribution of Prelaxation loss to the total power heat gen-
eration, Ptotal, was numerically compared by calculating both
Ptotal and Prelaxation loss from the experimentally obtained
Tac,mag, m at fappl=210 kHz, mass, and the volumetric
heat capacity values of MnxZn1−xFe2O4 SPNPs. As can be
seen in Fig. 3c, more than 80% or 90% of Prelaxation loss
contributed to the Ptotal of MnxZn1−xFe2O4 SPNPs verifying
that the Prelaxation loss, particularly the Néel relaxation power
loss is dominant for the Tac,mag of MnxZn1−xFe2O4 SPNPs.
To consider the SPNPs for a real clinical MH agent without
systemic side effect, the SPNPs should generate a higher
Tac,mag both in a short heat up time and with a amount as
low as possible. These characteristics can be evaluated by the
SAR shown in Fig. 3c.13 The Mn0.5Zn0.5Fe2O4 SPNP
showed the largest SAR value of 138.4 W/g due to the fastest
temperature rising rate T /t caused by the highest 
value among the MnxZn1−xFe2O4 SPNPs. This value is con-
sidered to be much higher than those obtained from the con-
ventional ternary phase SPNAs at the same ac condition,
e.g., Fe3O4 27.3 W/g, CoFe2O4 56.1 W/g, and NiFe2O4
12.6 W/g.14
The cell viability of MnxZn1−xFe2O4 SPNPs with differ-
ent concentrations was quantitatively estimated to explore
the feasibility to a MH agent particularly targeted for brain
tumors. Figure 4 showed the cell survival rate treated for a
one day and b two weeks, respectively. It was clearly con-
firmed that the cell survival rate of MnxZn1−xFe2O4 SPNPs
depends on the concentration of NPs in the cell culture me-
dia as well as the Mn2+ cation concentration. All three SP-
NPs showed midcytotoxicity or noncytotoxicity. In particu-
lar, the Mn0.5Zn0.5Fe2O4 SPNP had the highest cell survival
rate of 80%8% 10% of standard deviation even at a
higher NP concentration and for a long treatment time. The
higher cell survival rate of Mn0.5Zn0.5Fe2O4 SPNP is thought
to be due to the chemically stable phase of Mn0.5Zn0.5Fe2O4,
which is expected to induce less stress on the cells and the
large portion of Mn2+ cation concentration, which is consid-
ered to have a high biocompatibility.15
In conclusion, it was demonstrated that the Tac,mag and
the magnetic properties of MnxZn1−xFe2O4 SPNPs had a
strong dependence on the Mn2+ cation concentration. Among
the MnxZn1−xFe2O4 SPNPs, the Mn0.5Zn0.5Fe2O4 SPNP
showed the highest Tac,mag, SAR, and biocompatibility,
which make it suitable for MH agent applications. The
higher  value directly relevant to the N or ac magnetic
softness and the higher chemical stability systematically
controlled by the replacement of Zn2+ cations by the Mn2+
cations on the A-site are the primary physical reason for the
biotechnical promises of Mn0.5Zn0.5Fe2O4 SPNP.
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FIG. 4. Cell viability of superparamagnetic MnxZn1−xFe2O4 nanoparticles
x=0.33, 0.5, and 0.67 in MTT assay with NSCs isolated from human fetal
midbrain treated for a one day and b two weeks.
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